Literature DB >> 16753624

Two cases of papillary glioneuronal tumours.

S Epelbaum1, M Kujas, R Van Effenterre, J Poirier.   

Abstract

We report two cases of papillary glioneuronal tumour. Both patients underwent gross total resection of their tumour. One of them was also treated by radiotherapy. Neither tumour had recurred, 19 and 2 years after treatment, thus confirming the good prognosis commonly associated with this tumour.

Entities:  

Mesh：

Year:  2006        PMID： 16753624     DOI： 10.1080/02688690600682465

Source DB:  PubMed          Journal:  Br J Neurosurg        ISSN： 0268-8697            Impact factor:   1.596


  5 in total

1.  Papillary glioneuronal tumor-evidence of stem cell origin with biphenotypic differentiation.

Authors:  Aparna Govindan; A Mahadevan; D I Bhat; A Arivazhagan; Shrijeet Chakraborti; M S Suja; A A Phalguni; S Sampath; B A Chandramouli; S K Shankar
Journal:  J Neurooncol       Date:  2009-04-30       Impact factor: 4.130

Review 2.  Papillary glioneuronal tumor--a rare entity: report of four cases and brief review of literature.

Authors:  Shipra Agarwal; Mehar Chand Sharma; Geetika Singh; Vaishali Suri; Chitra Sarkar; Ajay Garg; Rajinder Kumar; P Sharat Chandra
Journal:  Childs Nerv Syst       Date:  2012-08-07       Impact factor: 1.475

3.  Atypical papillary glioneuronal tumor.

Authors:  Jesús Vaquero; Santiago Coca
Journal:  J Neurooncol       Date:  2007-02-07       Impact factor: 4.506

4.  Papillary glioneuronal tumor: a new entity awaiting inclusion in WHO classification.

Authors:  B D Radotra; Yashwant Kumar; Alka Bhatia; Sandeep Mohindra
Journal:  Diagn Pathol       Date:  2007-02-08       Impact factor: 2.644

5.  An individual patient data meta-analysis on characteristics and outcome of patients with papillary glioneuronal tumor, rosette glioneuronal tumor with neuropil-like islands and rosette forming glioneuronal tumor of the fourth ventricle.

Authors:  Annika Schlamann; André O von Bueren; Christian Hagel; Isabella Zwiener; Clemens Seidel; Rolf-Dieter Kortmann; Klaus Müller
Journal:  PLoS One       Date:  2014-07-03       Impact factor: 3.240
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.